Body burdens of brominated flame retardants and other persistent organo-halogenated compounds and their descriptors in US girls☆
Introduction
During the last few decades, concern has grown about the health effects of exposure to environmental contaminants that have hormonally active properties. While some of the chemicals of original concern were banned in many Westernized countries (such as DDT/DDE and PCBs), they are persistent in the environment. More recently, levels of a class of brominated flame retardants, the polybrominated diphenyl ethers (PBDEs), have been found to be increasing in the environment and subsequently in human biospecimens, and are present at higher concentrations in human serum and milk in the US than in Europe (Hites, 2004; Norstrom et al., 2002; Sjodin et al., 2004a). In contrast, levels of PCBs have been declining since the 1970s (Sjodin et al., 2004a). The PBDE studies have tended to include only adults (Bradman et al., 2007a, Bradman et al., 2007b; Hites, 2004; Petreas et al., 2002; Sjodin, 2004a; Schecter et al., 2005; Thomsen et al., 2002) and although there is much data on PCBs and DDT/DDE in adults and newborns, levels of these compounds are not routinely monitored in children under age 12 y. The Centers for Disease Control and Prevention (CDC, 2005) reports concentrations of these potential hormonally active agents (HAAs) in older children (12–19 y) in the National Health and Nutrition Examination Survey (NHANES); more recent data on PBDEs were published separately (Sjodin et al., 2008) and in the very recent new report (CDC, 2009).
Exposure to these persistent compounds in children is primarily through the diet (including breast feeding), as well as dust or inhalation for PBDEs (Lorber, 2008). As the reproductive system does not fully mature until later puberty during adolescence, chemicals that affect the endocrine system might potentially alter such development. The observed trend towards pubertal development occurring at younger ages (Hermann-Giddens et al., 1997; Euling et al., 2008) has raised the possibility that exogenous exposures may be contributing factors. Due to these concerns and the association of early menarche with increased risk of breast cancer, a study of determinants of puberty in girls is being conducted within the NIEHS/NCI-sponsored Breast Cancer and the Environment Research Centers (BCERC), which include transdisciplinary research collaborations integrated across biologic, epidemiologic, and community outreach projects. Of primary interest are exposures to potential HAAs in young girls before breast development (Hiatt et al., 2009). Working with community representatives, laboratory staff at the National Center for Environmental Health of the Centers for Disease Control and Prevention (CDC), and the relevant literature, we identified numerous compounds for evaluation in a small pilot sample of girls who provided urine and serum specimens (Pinney et al., 2008; Windham et al., 2008; Wolff et al., 2007a). Factors considered in determining which chemical families were subsequently measured in the entire cohort included high detection frequency and adequate variability. This current analysis focuses on persistent organo-halogenated compounds measured in serum, which was collected at two sites. To provide data lacking on children of this age (6–9 y), our goal was to characterize the distribution of these compounds and to compare them by geographic and other common demographic variables.
Section snippets
Study population
In the BCERC epidemiologic studies, girls ages 6–8 y at enrollment are being followed to measure onset and progression of pubertal maturation, including breast and pubic hair development. This longitudinal study began in 2005 at three sites: (1) Mount Sinai School of Medicine, which recruited girls through clinics, schools, and neighborhood centers in East Harlem in New York City; (2) Cincinnati Children’s Hospital/University of Cincinnati, Ohio (abbreviated as OH site), which recruited through
Results
Age at blood draw ranged from 6 to 10 y (the only 10-year-old had recently turned 10), with the majority aged 7–8 y old (Table 1). The sample was racially diverse with 52% white overall, and of fairly high socioeconomic status (SES) based on education level of the care-giver. About one-third of the girls had a BMI indicating risk for obesity and the majority had been breast-fed (Table 1). There were some differences between the two sites with girls from CA being older at blood draw, having older
Discussion
Our results show that many of these potential hormonally active agents, most of which have been little studied previously in children of this age, were detectable in a large proportion of young girls, some at relatively high levels. Concentrations of many, most consistently the PBDEs, varied by geographic location with higher levels found in the California site. There were variations by race, with Blacks having the highest mean PBDE levels, but about 50% lower mean PCB levels and slightly lower
Acknowledgments
We wish to acknowledge the contributions of numerous BCERC collaborators, including Drs. Mary Wolff, Susan Teitelbaum and Antonia Calafat, as well as the field staff at each site; Janice Barlow, M. Kathryn Brown and other members of the Community Outreach and Translation Core; and Dr. Gwen Collman. We thank Isaac J. Ergas, Lixia Zhang, Ling Shen, and Lusine Yaghjyan for initial data management and analyses.
References (41)
- et al.
Pubertal growth and development and prenatal and lactational exposure to polychlorinated biphenyls and dichlorodiphenyl dichloroethene
J Pediatr
(2000) - et al.
Guidelines for overweight in adolescent preventive services: recommendations from an expert committee. The Expert Committee on Clinical Guidelines for Overweight in Adolescent Preventive Services
Am. J. Clin. Nutr.
(1994) - et al.
Childhood growth and exposure to dichlorodiphenyl dichloroethene and polychlorinated biphenyls
J. Pediatr.
(2002) - et al.
Organochlorine chemicals and children’s health (editorial)
J. Pediatr.
(2002) - et al.
Age at menarche and tanner stage in girls exposed in utero and postnatally to polybrominated biphenyl
Epidemiology
(2000) - et al.
Polybrominated diphenyl ether levels in the blood of pregnant women living in an agricultural community in California
Environ. Health Perspect.
(2007) - Bradman A.S.A., Schwartz J.M., Fenster L., Barr D.B., Holland N.T., Eskenazi B., 2007b. Factors predicting...
- CA Technical Bulletin 117, 2000. Requirements, test procedures and apparatus for testing the flame retardance of...
- et al.
Influence of breastfeeding in the accumulation of polybromodiphenyl ethers during the first years of child growth
Environ. Sci. Technol.
(2007) - Centers for Disease Control and Prevention (CDC), 2000. CDC Growth Charts: United States. Available at...
Examination of US puberty-timing data from 1940 to 1994 for secular trands: panel findings
Pediatrics
Determinants of serum concentrations of organochlorine compounds in Swedish pregnant women: a cross-sectional study
Environ. Health
Growth abnormalities in the population exposed in utero and early postnatally to polychlorinated biphenyls and dibenzofurans
Environ. Health Perspect.
Determinants of prenatal exposure to polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs) in an urban population
Environ. Health Perspect.
In utero polychlorinated biphenyl exposures in relation to fetal and early childhood growth
Epidemiology
Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network
Pediatrics
The Breast Cancer and the Envronment Research Centers: transdisciplinary research on the role of the environment in breast cancer etiology
Environ. Health Perspect.
Polybrominated diphenyl ethers in the environment and in people: a meta-analysis of concentrations
Environ. Sci. Technol.
Cited by (0)
- ☆
Funding Sources: This work was funded by the National Institute of Environmental Health Sciences (NIEHS) and the National Cancer Institute (NCI), NIH, DHHS to the Breast Cancer & the Environment Research Centers at the University of California San Francisco Helen Diller Family Comprehensive Cancer Center (U01 ES012801) and the University of Cincinnati/Cincinnati Children’s Hospital Medical Center (U01 ES12770), with support from the University of Cincinnati Center for Environmental Genetics (P30-ES006096), the CA Department of Public Health (CDPH), and the NIH/NCRR-sponsored UCSF Center for Translational Science Institute (UL1 RR024131). The contents of this report are solely the responsibility of the authors and do not necessarily represent the official views of the NIEHS, the NCI, the CDC, or the CDPH. Before initiation of the study, human subjects approval was obtained from the IRBs of the institutions carrying out subject recruitment and data collection, e.g. Kaiser Permanente, Northern California (no.: CN-04LKush-04-H, last re-approved on 14 October 2008) and the University of Cincinnati (CCHMC IRB no. 03-18-05, last re-approved on 1 November 2008).